[HTML][HTML] Whole transcriptome analysis reveals non-coding RNA's competing endogenous gene pairs as novel form of motifs in serous ovarian cancer

H Li, X Zheng, J Gao, KS Leung, MH Wong… - Computers in biology …, 2022 - Elsevier
The non-coding RNA (ncRNA) regulation appears to be associated to the diagnosis and
targeted therapy of complex diseases. Motifs of non-coding RNAs and genes in the …

NUSAP1 binds ILF2 to modulate R-loop accumulation and DNA damage in prostate cancer

CL Chiu, CG Li, E Verschueren, RM Wen… - International journal of …, 2023 - mdpi.com
Increased expression of NUSAP1 has been identified as a robust prognostic biomarker in
prostate cancer and other malignancies. We have previously shown that NUSAP1 is …

Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors

T Gao, L Zhao, F Zhang, C Cao, S Fan, X Shi - World journal of surgical …, 2022 - Springer
Background Nucleolar spindle-associated protein 1 (NUSAP1) is reported to be a useful
diagnostic and prognostic marker for a variety of cancers, but relevant studies are lacking in …

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

R Gou, M Zheng, Y Hu, L Gao, S Wang, O Liu, X Li… - BMC cancer, 2022 - Springer
Background Nucleolar and spindle-associated protein 1 (NUSAP1) was shown to be
involved in cell cycle regulation in cancer. However, its prognostic value and underlying …

GSG2 promotes development and predicts poor prognosis of ovarian cancer

Y Huang, Y Liu, K Zhu, X Ma, R Lu… - Cancer Management and …, 2021 - Taylor & Francis
Purpose Ovarian cancer is one of the most common malignant tumors in gynecology, whose
treatment was seriously limited by the unclear understanding of molecular mechanism in …

[HTML][HTML] Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy

M Wei, X Bai, Q Dong - Translational Cancer Research, 2022 - ncbi.nlm.nih.gov
Identification of novel candidate genes and small molecule drugs in ovarian cancer by
bioinformatics strategy - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Expression Profile and Gene Regulation Network of NUSAP1 in Pan Cancers Based on Integrated Bioinformatics Analysis

X Zhu, Y Wu, L Liao, W Huang, L Yuan… - … Journal of General …, 2023 - Taylor & Francis
Background Nucleolar and spindle-associated protein 1 (NUSAP1) plays key roles in
microtubules and chromosomes in normal cells both structurally and functionally. In …

去势抵抗性前列腺癌潜在关键基因的生物信息学分析

董婧婷, 衡立, 康绍叁, 刘健, 田志崇, 张立国, 张金存… - 中国全科医学, 2022 - chinagp.net
背景去势抵抗性前列腺癌(CRPC) 是男性常见恶性肿瘤疾病之一, 病死率高,
分子机制仍不十分清楚, 且无有效治疗药物. 目的应用生物信息学方法挖掘CRPC 发生 …

[HTML][HTML] Lncrna FGFR3-AS1 Is a Prognostic Indicator for Ovarian Cancer and Induces Cell Proliferation and Hinders Apoptosis

Y Zhang, L Sun, T Chen, Y Yue, L Zhao… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Background: Ovarian cancer is one of the most common malignant tumors in Gynecology,
whose treatment was seriously limited by the unclear understanding of molecular …

[PDF][PDF] NuSAP1, LDLR 与局部晚期乳腺癌患者腋窝淋巴结转移的关系及其危险因素分析

陈新宽, 杨海燕, 梁伟 - 肿瘤代谢与营养电子杂志 - 182.92.200.144
目的探讨核仁纺锤体相关蛋白1 (NuSAP1), 低密度脂蛋白受体(LDLR) 与局部晚期乳腺癌患者
腋窝淋巴结转移情况的关系, 并分析患者腋窝淋巴结转移≥ 10 枚的危险因素. 方法选取2018 …